ProCE Banner Activity

在 EACS 2021 之后影响我的实践的重要研究

Slideset Download
Conference Coverage
阅读专家教员对 EACS 2021 的重要研究的总结,包括测试和治疗模型中 BIC/FTC/TAF 的研究结果;伊斯拉韦和多拉韦林用于治疗初治患者;M184V 突变患者的 DTG/3TC;按 BMI 类别、患者满意度和停药后结果的长效 CAB + RPV;lenacapavir 用于重度治疗的患者; 和 COVID-19 疫苗的有效性以及大流行对 PWH 病毒学抑制的影响。

Released: December 14, 2021

Expiration: December 13, 2022

No longer available for credit.
Begin Activity

Share

Faculty

Tristan J. Barber

Tristan J. Barber, MA, MD, FRCP

Honorary Associate Professor
Institute for Global Health
University College London
Consultant in HIV Medicine
Ian Charleson Day Centre
Royal Free Hospital
London, United Kingdom

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Jürgen K. Rockstroh

Jürgen K. Rockstroh, MD

Professor of Medicine
University Hospital Bonn
Department of Medicine I
Bonn, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

教育补助金提供者

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare

Faculty Disclosure

Primary Author

Tristan J. Barber, MA, MD, FRCP

Honorary Associate Professor
Institute for Global Health
University College London
Consultant in HIV Medicine
Ian Charleson Day Centre
Royal Free Hospital
London, United Kingdom

Tristan J. Barber(文学硕士,医学博士,FRCP)披露他已获得 Roche 的研究支持资金;Gilead Sciences、MDS、Theratechnologies 和 ViiV 支付的咨询费;Gilead Sciences、MDS 和 ViiV 的非 CME/CE 服务费用; 以及来自 Gilead Sciences 和 ViiV 的其他经济或物资支持。

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Jürgen K. Rockstroh, MD

Professor of Medicine
University Hospital Bonn
Department of Medicine I
Bonn, Germany